Your browser doesn't support javascript.
loading
Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Chugh, Seema; Barkeer, Srikanth; Rachagani, Satyanarayana; Nimmakayala, Rama Krishna; Perumal, Naveenkumar; Pothuraju, Ramesh; Atri, Pranita; Mahapatra, Sidharth; Thapa, Ishwor; Talmon, Geoffrey A; Smith, Lynette M; Yu, Xinheng; Neelamegham, Sriram; Fu, Jianxin; Xia, Lijun; Ponnusamy, Moorthy P; Batra, Surinder K.
Afiliación
  • Chugh S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Barkeer S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Rachagani S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Nimmakayala RK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Perumal N; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Pothuraju R; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Atri P; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Mahapatra S; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Thapa I; School of Interdisciplinary Informatics, University of Nebraska at Omaha, Omaha, Nebraska.
  • Talmon GA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Smith LM; Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska.
  • Yu X; Department of Chemical and Biological Engineering, Clinical and Translational Research Center, University at Buffalo, The State University of New York, Buffalo, New York.
  • Neelamegham S; Department of Chemical and Biological Engineering, Clinical and Translational Research Center, University at Buffalo, The State University of New York, Buffalo, New York.
  • Fu J; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.
  • Xia L; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.
  • Ponnusamy MP; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center,
  • Batra SK; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center,
Gastroenterology ; 155(5): 1608-1624, 2018 11.
Article en En | MEDLINE | ID: mdl-30086262
ABSTRACT
BACKGROUND &

AIMS:

Pancreatic ductal adenocarcinomas (PDACs) produce higher levels of truncated O-glycan structures (such as Tn and sTn) than normal pancreata. Dysregulated activity of core 1 synthase glycoprotein-N-acetylgalactosamine 3-ß-galactosyltransferase 1 (C1GALT1) leads to increased expression of these truncated O-glycans. We investigated whether and how truncated O-glycans contributes to the development and progression of PDAC using mice with disruption of C1galt1.

METHODS:

We crossed C1galt1 floxed mice (C1galt1loxP/loxP) with KrasG12D/+; Trp53R172H/+; Pdx1-Cre (KPC) mice to create KPCC mice. Growth and progression of pancreatic tumors were compared between KPC and KPCC mice; pancreatic tissues were collected and analyzed by immunohistochemistry; immunofluorescence; and Sirius red, alcian blue, and lectin staining. We used the CRISPR/Cas9 system to disrupt C1GALT1 in human PDAC cells (T3M4 and CD18/HPAF) and levels of O-glycans were analyzed by lectin blotting, mass spectrometry, and lectin pulldown assay. Orthotopic studies and RNA sequencing analyses were performed with control and C1GALT1 knockout PDAC cells. C1GALT1 expression was analyzed in well-differentiated (n = 36) and poorly differentiated (n = 23) PDAC samples by immunohistochemistry.

RESULTS:

KPCC mice had significantly shorter survival times (median 102 days) than KPC mice (median 200 days) and developed early pancreatic intraepithelial neoplasias at 3 weeks, PDAC at 5 weeks, and metastasis at 10 weeks compared with KPC mice. Pancreatic tumors that developed in KPCC mice were more aggressive (more invasive and metastases) than those in KPC mice, had a decreased amount of stroma, and had increased production of Tn. Poorly differentiated PDAC specimens had significantly lower levels of C1GALT1 than well-differentiated PDACs. Human PDAC cells with knockout of C1GALT1 had aberrant glycosylation of MUC16 compared with control cells and increased expression of genes that regulate tumorigenesis and metastasis.

CONCLUSIONS:

In studies of KPC mice with disruption of C1galt1, we found that loss of C1galt1 promotes development of aggressive PDACs and increased metastasis. Knockout of C1galt1 leads to increased tumorigenicity and truncation of O-glycosylation on MUC16, which could contribute to increased aggressiveness.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Galactosiltransferasas Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Galactosiltransferasas Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2018 Tipo del documento: Article